Role of CD8+ lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment

被引:242
作者
Lifson, JD
Rossio, JL
Piatak, M
Parks, T
Li, L
Kiser, R
Coalter, V
Fisher, B
Flynn, BM
Czajak, S
Hirsch, VM
Reimann, KA
Schmitz, JE
Ghrayeb, J
Bischofberger, N
Nowak, MA
Desrosiers, RC
Wodarz, D
机构
[1] NCI, Retroviral Pathogenesis Lab, AIDS Vaccine Program, SAIC Frederick, Ft Detrick, MD 21702 USA
[2] NCI, Vaccine Support Lab, AIDS Vaccine Program, SAIC Frederick, Ft Detrick, MD 21702 USA
[3] NCI, Anim Sci Branch, Bethesda, MD 20892 USA
[4] Harvard Univ, New England Reg Primate Res Ctr, Sch Med, Southborough, MA 01772 USA
[5] NIAID, Mol Microbiol Lab, NIH, Rockville, MD 20852 USA
[6] Centocor Inc, Malvern, PA 19355 USA
[7] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA
[8] Gilead Sci Inc, Foster City, CA 94404 USA
[9] Inst Adv Study, Program Theoret Biol, Princeton, NJ 08540 USA
关键词
D O I
10.1128/JVI.75.21.10187-10199.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Transient antiretroviral treatment with tenofovir, (R)-9-(2-phosphonylmethoxypropyl) adenine, begun shortly after inoculation of rhesus macaques with the highly pathogenic simian immunodeficiency virus (SIV) isolate SIVsmE660, facilitated the development of SIV-specific lymphoproliferative responses and sustained effective control of the infection following drug dis continuation. Animals that controlled plasma viremia following transient postinoculation treatment showed substantial resistance to subsequent intravenous rechallenge with homologous (SIVsmE660) and highly heterologous (SIVmac239) SIV isolates, up to more than 1 year later, despite the absence of measurable neutralizing antibody. In some instances, resistance to rechallenge was observed despite the absence of detectable SIV-specific binding antibody and in the face of SIV lymphoproliferative responses that were low or undetectable at the time of challenge. In vivo monoclonal antibody depletion experiments demonstrated a critical role for CD8(+) lymphocytes in the control of viral replication; plasma viremia rose by as much as five log units after depletion of CD8(+) cells and returned to predepletion levels (as low as <100 copy Eq/ml) as circulating CD8(+) cells were restored. The extent of host control of replication of highly pathogenic SIV strains and the level of resistance to heterologous rechallenge achieved following transient postinoculation treatment compared favorably to the results seen after SIVsmE660 and SIVmac239 challenge with many vaccine strategies. This impressive control of viral replication was observed despite comparatively modest measured immune responses, less than those often achieved with vaccination regimens. The results help establish the underlying feasibility of efforts to develop vaccines for the prevention of AIDS, although the exact nature of the protective host responses involved remains to be elucidated.
引用
收藏
页码:10187 / 10199
页数:13
相关论文
共 47 条
  • [1] The role of CD4+ T helper cells in the cytotoxic T lymphocyte response to HIV-1
    Altfeld, M
    Rosenberg, ES
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (04) : 375 - 380
  • [2] Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection
    Altfeld, M
    Rosenberg, ES
    Shankarappa, R
    Mukherjee, JS
    Hecht, FM
    Eldridge, RL
    Addo, MM
    Poon, SH
    Phillips, MN
    Robbins, GK
    Sax, PE
    Boswell, S
    Kahn, JO
    Brander, C
    Goulder, PJR
    Levy, JA
    Mullins, JI
    Walker, BD
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) : 169 - 180
  • [3] Arthur LO, 1998, AIDS RES HUM RETROV, V14, pS311
  • [4] Carter DL, 1999, CYTOMETRY, V37, P41, DOI 10.1002/(SICI)1097-0320(19990901)37:1<41::AID-CYTO5>3.0.CO
  • [5] 2-4
  • [6] HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
    Collins, KL
    Chen, BK
    Kalams, SA
    Walker, BD
    Baltimore, D
    [J]. NATURE, 1998, 391 (6665) : 397 - 401
  • [7] Strategies used by human immunodeficiency virus that allow persistent viral replication
    Desrosiers, RC
    [J]. NATURE MEDICINE, 1999, 5 (07) : 723 - 725
  • [8] Chemokine receptors and chemokines in HIV infection
    Garzino-Demo, A
    Devico, AL
    Gallo, RC
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1998, 18 (04) : 243 - 255
  • [9] IMMUNIZATION WITH WHOLE INACTIVATED VACCINE PROTECTS FROM INFECTION BY SIV GROWN IN HUMAN BUT NOT MACAQUE CELLS
    GOLDSTEIN, S
    ELKINS, WR
    LONDON, WT
    HAHN, A
    GOEKEN, R
    MARTIN, JE
    HIRSCH, VM
    [J]. JOURNAL OF MEDICAL PRIMATOLOGY, 1994, 23 (2-3) : 75 - 82
  • [10] Intrinsic susceptibility of rhesus macaque peripheral CD4+ T cells to simian immunodeficiency virus in vitro is predictive of in vivo viral replication
    Goldstein, S
    Brown, CR
    Dehghani, H
    Lifson, JD
    Hirsch, VM
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (20) : 9388 - 9395